1
Return

Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts

delete1998-11-01
delete60
PRE
AI
A
Anna Ferrari *
M
Marco Bertolotti
E
E Sternieri
DOI:10.1016/S0376-8716(98)00098-2delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment despite the observation that the pharmacological effect of the drug is related to its plasma concentrations. In this study we investigated the time course of serum levels of naltrexone and its active metabolite, 6 beta-naltrexol, in 13 heroin addicts (3 F, 10 M; age 22-32 years) in the 24 h after 100 mg of naltrexone orally. Six patients were studied once, at different times during chronic treatment, whereas in seven patients the study was done at the beginning and after 1 month of naltrexone treatment. Four of these patients also repeated the study after 3 months of naltrexone treatment. Serum naltrexone and 6 beta-naltrexol were assayed by GLC with a nitrogen-phosphorus detector, Our results showed large differences among patients in serum naltrexone and 6 beta-naltrexol levels. On the other hand, there were no differences in serum time course of both substances in the same patient over 3 months. Peak levels and AUCs of naltrexone were lower than those of 6 beta-naltrexol in ten addicts and higher than those of the metabolite in three patients. No significant differences in the apparent half-lives of the two drugs were detected among groups. These data are consistent with the occurrence of a decreased first-pass metabolism of naltrexone in three patients leading to a larger availability of an oral dose. The increased bioavailability of the drug is not very important for opioid receptor antagonist activity but may play a role in naltrexone treatment safety. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
Keywords:
naltrexone
6 beta-naltrexol
drug addicts
pharmacokinetic
bioavailability
drug-interactions

Journal

Drug and Alcohol Dependence cover
Drug and Alcohol Dependence
IF:
3.6
Papers:
1.2W
Citations:
2.4W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers